Strategic Partnerships Gateway Analytical is an Aptar Pharma company with a focus on advanced analytical testing for pharmaceuticals, materials, and medical devices. This presents a sales opportunity to align with Aptar Pharma’s broader customer network, offering integrated particulate analysis services to drug, device, and materials suppliers seeking compliant, rapid turnaround testing.

Regulatory Momentum Recent milestones include cGMP-compliant automated ISPS methods and participation in industry events like PDA Week and BIO International, signaling strong regulatory alignment and adoption readiness. Target pharmaceutical manufacturers and contract manufacturers aiming to strengthen quality systems and regulatory submissions with robust particulate analysis.

Expanding Reach Gateway actively engages at major industry gatherings and has a global-minded service for foreign particulate analysis and identification. Sales opportunities exist with global pharma players, contract manufacturers, and medical device firms seeking high-accuracy particulates testing to support sterile manufacturing and injectable product safety.

Technology Differentiation Investment in automated ISPS measurements via wide-field Raman imaging positions Gateway as a tech-forward partner. Cross-sell to customers needing advanced materials characterization, Raman spectroscopy capabilities, and automated, scalable testing to shorten development cycles and support regulatory filings.

Financial Profile & Scale With revenue in the 10–25 million range and a lean team (11–50 employees) under Aptar Pharma, Gateway offers a nimble, high-quality analytics partner for mid-market pharmaceutical and medical device clients. Target mid-sized manufacturers and regional CDMOs seeking specialized testing without the overhead of larger labs.